Virology News and Research

Latest Virology News and Research

Tobacco plant-derived vaccines safeguard against Yersinia pestis

Through an innovative feat of plant biotechnology and vaccine design, researchers in the Biodesign Institute at Arizona State University have successfully turned tobacco plants into vaccine production factories to combat the deadliest form

10 Jan 2006

Viral 'fitness' explains different resistance patterns to AIDS drugs

Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. For other medications, resistance occurs only when patients take most of their pills.

10 Jan 2006

Russia ups the ante against bird flu yet again

As the avian bird flu virus continues its sweep across neighbouring Turkey, spreading panic in it's wake, the Russian President Vladimir Putin has instructed his government to take measures to prevent a new outbreak of bird flu in Russia.

10 Jan 2006

As Turks struggle with bird flu experts say it will be controlled

As local officials were sealing off parts of the major cities of Ankara and Istanbul and thousands of birds were being culled, Guenael Rodier, head of a World Health Organization (WHO) team sent to investigate the outbreak said he believes the outbreak can be brought under control relatively easily.

10 Jan 2006

European Medicines Agency receives first pandemic influenza vaccine application

The European Medicines Agency has received the first application for a pandemic influenza vaccine, submitted by GlaxoSmithKline Biologicals.

10 Jan 2006

Turks panic as bird flu sweeps across the country

Fears continue to grow in Turkey as more reports of suspected bird flu cases among people sweep across the country.

10 Jan 2006

HHS awards $56.9 million to tackle health disparities

HHS Secretary Mike Leavitt has announced the awarding of $56.9 million by the National Institutes of Health’s (NIH) National Center on Minority Health and Health Disparities (NCMHD).

10 Jan 2006

Genetic mutation that protects against HIV increases the risk of West Nile Virus infection

A genetic mutation that protects against HIV increases the risk of developing clinical West Nile Virus infection, according to a new study appearing online on January 9th in The Journal of Experimental Medicine.

9 Jan 2006

AIDS drugs from sunflowers

Sunflowers can produce a substance which prevents the AIDS pathogen HIV from reproducing, at least in cell cultures. This is the result of research carried out by scientists at the University of Bonn in cooperation with the caesar research centre.

9 Jan 2006

Turkey on alert as bird flu spreads

As the numbers of suspected bird flu cases in Turkey rises there is concern that the deadly virus is rapidly spreading across the country and is heading for mainland Europe.

9 Jan 2006

Travelers in Russia warned about bird flu in Turkey

Following the confirmation by officials that two children and one adult have tested positive for the deadly H5N1 bird flu strain in Turkey's capital Ankara, Russians are being warned against traveling to Turkey.

8 Jan 2006

New technique points to safer, more efficient vaccination

Researchers have demonstrated a technique that has the potential to reduce the toxicity of vaccines and to make smaller doses more effective, according to a study published in PLoS Pathogens.

6 Jan 2006

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

6 Jan 2006

Fruit bats a reservoir for Ebola virus

IRD researchers have succeeded in the first identification of bats as a potential natural reservoir of Ebola virus. Several epidemics of haemorrhagic fever have raged in the Republic of Congo and Gabon since 2001, hitting both humans and primates simultaneously.

6 Jan 2006

Risk factors for nongonococcal urethritis

The study, by Australian researchers Catriona Bradshaw, MD, and colleagues at the Melbourne Sexual Health Centre, is the first major case-control study to simultaneously address all currently hypothesized causes of NGU.

6 Jan 2006

Rotateq eliminates the most severe cases of rotavirus

In a study of more than 68,000 infants published in the New England Journal of Medicine, the investigational vaccine Rotateq demonstrated that it can safely prevent 98 percent of severe cases of viral diarrhea and vomiting that account for 2 million hospital visits and 500,000 pediatric deaths each year worldwide.

6 Jan 2006

Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation

Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy against Hepatitis C virus in vitro.

5 Jan 2006

Molecular finding will help better understand measles and mumps

A team of Northwestern University researchers has solved the structure of a molecule that controls the ability of viruses of the paramyxovirus family, including the viruses that cause measles, mumps, and many human respiratory diseases, to fuse with and infect human cells.

5 Jan 2006

Abstinence and Abstinence-Only Education: A Review of U.S. Policies and Programs

While few Americans remain abstinent until marriage and most initiate sexual intercourse as adolescents, abstinence from sexual intercourse is an important behavioral strategy for preventing human immunodeficiency virus, other sexually transmitted infections, and unintended pregnancy among adolescents

5 Jan 2006

Limitation of combination therapy of Interferon and Ribavirin for older patients with chronic hepatitis C

A new Japanese study examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group.

5 Jan 2006